Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GTO vs Apatos for Immediate Post-extractive Implants
NCT07047131Phase 3Active, not recruiting
- Start
- Dec 2018
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial (2 arms). Primary endpoint: Changes in peri-implant bone volumes at 5 years. Started Dec 2018; status: active, not recruiting.
Beyond the preview
Go deeper on NCT07047131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07047131.